Showing results (871-880 of 1,119) with videos related to

Sort By:
Pageof 112
Translational Psychiatry|August 2, 2017
Genome-wide association analysis identifies common variants influencing infant brain volumesK Xia, J Zhang, M Ahn, et al.
JAMA Psychiatry|April 2, 2015
Polygenic Risk Score, Parental Socioeconomic Status, Family History of Psychiatric Disorders, and the Risk for Schizophrenia: A Danish Population-Based Study and Meta-analysisEsben Agerbo, Patrick F Sullivan, Bjarni J Vilhjálmsson, et al.
Psychiatric Services (Washington, D.C.)|August 28, 2019
Screening and Intervention for Suicide Prevention: A Cost-Effectiveness Analysis of the ED-SAFE InterventionsLaura J Dunlap, Stephen Orme, Gary A Zarkin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 12, 2009
Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesityFredric P Manfredsson, Nihal Tumer, Benedek Erdos, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 1, 2025
Delineating lifetime multimorbidity associated with 16p13.11 duplication: A literature review, meta-analysis, and case studyRose Mary Xavier, Wenxin Bian, Fadhah Alshammari, et al.
The Pharmacogenomics Journal|November 17, 2010
Antipsychotic-induced vacuous chewing movements and extrapyramidal side effects are highly heritable in miceJ J Crowley, D E Adkins, A L Pratt, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 9, 2014
Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorderAmy B Hart, Eric R Gamazon, Barbara E Engelhardt, et al.
Clinical Epigenetics|April 8, 2024
Meta-analysis of epigenetic aging in schizophrenia reveals multifaceted relationships with age, sex, illness duration, and polygenic riskAnil P S Ori, Loes M Olde Loohuis, Jerry Guintivano, et al.
Molecular Psychiatry|March 3, 2010
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsD E Adkins, K Aberg, J L McClay, et al.
Molecular Psychiatry|December 12, 2018
Common-variant associations with fragile X syndromeJames J Crowley, Jin Szatkiewicz, Anna K Kähler, et al.
Pageof 112